Ongoing Support STEP 3 Physician guidance for dose adjustments, side-effect management, and long-term success
You met one of Medicares clinical criteria when you first started GLP-1 therapy
Strength increases typically follow within two to three weeks
Eli Lilly spokesperson Michael Jamison said in a written comment that telehealth companies sued by the drug manufacturer threaten patient safety by falsely promoting supposedly personalized compounded tirzepatide and mislead consumers about the safety, clinical testing, and effectiveness of their compounded knockoffs. Meanwhile, Novo Nordisk has filed 130 lawsuits against entities engaged in unlawful marketing and sale of knockoff semaglutide drugs, said Liz Skrbkova, a spokesperson for the drugmaker
The most effective treatment plan depends on the individual
In the landmark, large clinical studies of both semaglutide and tirzepatide for weight loss, participants took 1.7 or 2.4 mg of semaglutide and 5, 10, or 15 mg of tirzepatide